Molecular Identification of Arboviral Infections (Dengue, Chikungunya, Yellow Fever, Rift Valley Fever, Mayaro, West Nile, and Zika) in Acute Febrile Illnesses Without Malaria in Kenya's Garissa and Mombasa Counties, July 2023 and July 2024

• by Abdi Roba, John Kiiru, Elvis Kirui, Paul Langat, Marygorett Mbeneka, Mellap Wanyonyi, Judith Nasengo, Hakim I. Lagu, Emmanuel Achol, Muna Affara, Florian Gehre, Hussein Hassan, Evans Odiambo, Fatuma Dugay, Aden Hussein, Frankline Okemwa, Salma Swaleh, Suleiman Thani, Rose Gichana, Isaiah Karissa, Millicent Ndia

• January 9, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

A tiered molecular surveillance framework linking rapid dengue detection to genomic epidemiology in Senegal

• by Amy Gaye, Varun Vaidya, Mariama Toure, Ibrahima Mbaye Ndiaye, Sebastian Gallon, Mamadou Samb Yade, Bassirou Ngom, Djiby Sow, Ndeye Coumba Diop, Ousmane Kebe, Yaye Die Ndiaye, Mamadou Alpha Diallo, Aita Sene, Abdoulaye Tine, Awa Bineta Deme, Younousse Diedhiou, Abdoulaye Kane Dia, Aida S. Badiane, Mouhamad Sy, Daouda Ndiaye

• August 25, 2026